Michel Ducreux

机构：Inserm, Université Paris-Saclay, Institut Gustave Roussy · ORCID：0000-0001-8649-7449

发表论文 1103 篇 · 总被引 72521 次 · h-index 116

代表论文

• Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer (2025 · JAMA Oncology · 被引 7)
• Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients (2025 · npj Precision Oncology · 被引 4)
• Precision medicine strategy in pancreatic ductal adenocarcinoma (2025 · ESMO Open · 被引 4)
• Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patients (2025 · European Journal of Cancer · 被引 3)
• Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment (2025 · European Journal of Cancer · 被引 2)
• A phase 2/3 randomized study of BMS-986504 with nab-paclitaxel (nab-P) and gemcitabine (GEM) in first-line (1L) metastatic pancreatic ductal adenocarcinoma (PDAC) with homozygous MTAP deletion ( MTAP -del): MountainTAP-30. (2026 · Journal of Clinical Oncology · 被引 1)